FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose ...
MedPage Today on MSN
FDA proposes more flexibility in alternatives to animal testing in drug development
Non-animal testing methods could save drugmakers time and money, officials say ...
Morning Overview on MSN
FDA urges alternatives to animal testing in early-stage drug development
The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward ...
President, Wyoming Test Fixtures Inc. One of the recurring themes in this column over the past few years has been the development of new test methods for sandwich composites. This is primarily a ...
Following the trend of other regulators, the European Medicines Agency (EMA) is taking steps to reduce the need for animal testing. The agency has issued a draft qualification opinion for a new ...
The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...
In this chapter, we focus on two topics: the lack of enforcement of existing U.S. Department of Defense (DOD) guidelines and procedures and the role of the program manager in the acquisition process.
The role of in vitro testing in modern cosmetic development Ensuring the safety and performance of cosmetic products is a critical requirement for manufacturers operating in today’s regulated and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results